We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+11.09%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$23.9B
AUM Growth
+$1.43B
Cap. Flow
-$1.37B
Cap. Flow %
-5.75%
Top 10 Hldgs %
23.75%
Holding
1,048
New
64
Increased
472
Reduced
416
Closed
27

Top Buys

Rank Stock Value
1
AMT icon
American Tower
AMT
+$114M
2
MA icon
Mastercard
MA
+$36.5M
3
IQV icon
IQVIA
IQV
+$24.7M
4
JD icon
JD.com
JD
+$21.2M
5
SE icon
Sea Limited
SE
+$19M

Top Sells

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$148M
2
LIN icon
Linde
LIN
+$94.3M
3
QGEN icon
Qiagen
QGEN
+$65.9M
4
AAPL icon
Apple
AAPL
+$53.3M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$51.8M

Sector Composition

Rank Sector Weight
1 Technology 23.17%
2 Financials 13.47%
3 Healthcare 11.82%
4 Consumer Discretionary 11.25%
5 Industrials 9.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZS icon
426
Zscaler
ZS
$27.3B
$7.79M 0.03%
24,260
+658
+3% +$207K
HBAN icon
427
Huntington Bancshares
HBAN
$35.5B
$7.78M 0.03%
504,810
+56,986
+13% +$898K
VMW
428
DELISTED
VMware, Inc
VMW
$7.76M 0.03%
66,957
+42,385
+172% +$5.57M
MKTX icon
429
MarketAxess Holdings
MKTX
$5.72B
$7.72M 0.03%
18,780
+3,611
+24% +$1.42M
FTS icon
430
Fortis
FTS
$28.7B
$7.62M 0.03%
158,078
-65,758
-29% -$2.98M
KHC icon
431
Kraft Heinz
KHC
$30B
$7.56M 0.03%
210,561
+7,650
+4% +$275K
RF icon
432
Regions Financial
RF
$26.8B
$7.54M 0.03%
346,102
-112,239
-24% -$2.57M
STE icon
433
Steris
STE
$23.1B
$7.53M 0.03%
30,934
+4,713
+18% +$1.08M
ABMD
434
DELISTED
Abiomed Inc
ABMD
$7.53M 0.03%
20,957
+2,920
+16% +$987K
PANW icon
435
Palo Alto Networks
PANW
$297B
$7.52M 0.03%
81,018
-16,242
-17% -$1.4M
STX icon
436
Seagate
STX
$184B
$7.48M 0.03%
66,212
+4,250
+7% +$413K
J icon
437
Jacobs Solutions
J
$17B
$7.39M 0.03%
64,216
-2,772
-4% -$320K
TDY icon
438
Teledyne Technologies
TDY
$32B
$7.36M 0.03%
16,838
+2,782
+20% +$1.21M
BIO icon
439
Bio-Rad Laboratories Class A
BIO
$9.42B
$7.36M 0.03%
9,735
+1,138
+13% +$852K
ENPH icon
440
Enphase Energy
ENPH
$5.53B
$7.31M 0.03%
39,942
-405
-1% -$84.5K
HES
441
DELISTED
Hess
HES
$7.3M 0.03%
98,648
+13,754
+16% +$1.12M
CLX icon
442
Clorox
CLX
$12.7B
$7.26M 0.03%
41,664
+4,088
+11% +$681K
HAL icon
443
Halliburton
HAL
$26.6B
$7.24M 0.03%
316,486
+45,544
+17% +$1.08M
TDG icon
444
TransDigm Group
TDG
$67.7B
$7.23M 0.03%
11,368
-1,003
-8% -$628K
PHM icon
445
Pultegroup
PHM
$25.3B
$7.22M 0.03%
126,310
+13,759
+12% +$705K
DPZ icon
446
Domino's
DPZ
$11.6B
$7.21M 0.03%
12,774
+1,561
+14% +$794K
BR icon
447
Broadridge
BR
$19B
$7.19M 0.03%
39,351
+3,966
+11% +$697K
LKQ icon
448
LKQ Corp
LKQ
$6.29B
$7.19M 0.03%
119,715
+36,417
+44% +$2.06M
POOL icon
449
Pool Corp
POOL
$7.5B
$7.18M 0.03%
12,695
-2,661
-17% -$1.39M
HIG icon
450
Hartford Financial Services
HIG
$39.3B
$7.18M 0.03%
104,022
-1,950
-2% -$138K

Similar funds

Aviva's Q4 2021 Portfolio in Review

As of Q4 2021, Aviva held 1,048 positions worth $23.9B, up 6.4% from $22.4B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Aviva withdrew a net $1.37B in Q4 2021, closing 27 positions and reducing 416 holdings. Its most notable exit was Coresite Realty Corporation, an estimated $33.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Aviva opened a new position in Rivian worth $4.38M.

  • Aviva's largest Q4 2021 buy was Rivian: 42,209 shares worth $4.38M.
  • Aviva added most to American Tower in Q4 2021, an estimated $114M increase.
  • Aviva's biggest Q4 2021 reduction was Stellantis, cutting an estimated $148M.
  • Aviva fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $33.7M.
  • Aviva's ten largest holdings make up 24% of its $23.9B portfolio in Q4 2021.
  • Aviva opened 64 new positions and closed 27 in Q4 2021.
  • Aviva's portfolio value rose 6.4% quarter-over-quarter to $23.9B.

Based on Aviva's 13F filing for Q4 2021, filed 10 Feb 2022.